您的瀏覽器不支援JavaScript功能,若網頁功能無法正常使用時,請開啟瀏覽器JavaScript狀態!
Some images has been designed using resources from
Unsplash
&
Pixabay
&
Pexels
&
Freepik
and some icons from
Flaticon
跳到主要內容
:::
Home
Sitemap
International
Facebook
小
中
大
Branches
Suao
Yuanshan
Taoyuan
Hsinchu
Yu-Li
Fenglin
Taitung
Gan-Dau
Department of Chest Medicine ,Taipei veterans general hospital
Worlds Best Hospitals
搜尋
Open main menu
Search
Search
About us
Doctors
Chief
Yuh-Min Chen
Division of General Chest Medicine
Division of Thoracic Oncology
Division of Clinical Respiratory Physiology
Division of Pulmonary Immunology & Infectious Diseases
Division of Respiratory Therapy
Outpatient
Center of Sleep Medicine
About us
Doctors
Photos
English version dietary
Further links
International Medical Service
Hyperbaric Oxygen Therapy
Therapeutical and Research Center of Lung Tumor
Links
Search
Search
簡介
緣起
宗旨
組織架構
業務內容及服務項目
遺傳疾病諮詢服務門診
發展現況
未來發展
新生兒篩檢
歷年診斷人數統計
罕病照護(國健署計畫)
歷年活動
2024
2023
亞太區族群基因體學與精準醫學論壇
遺傳內分泌科亞洲遺傳代謝病國際會議,發表了五篇口頭報告和八篇海報,是各國參與者中最多。
兒科李麗虹護理師榮獲南丁格爾獎績優奉獻銅獎
10秒完成大數據搜尋!臺北榮總打造全基因定序分析系統,還導入AI來預測用藥風險
臺北榮民總醫院、道品股份有限公司、和鼎資産管理股份有限公司三方產學合作所開發的「精準醫療之基石-即時全基因分析系統」參加「財團法人生技醫療科技政策研究中心」所舉辦的第二十屆新創獎,榮獲「臨床新創獎」
2022
《博士開講》牛道明:全基因定序 有效防癌症與猝逝
龐貝氏症治療領先世界
衛生福利部季刊-第33期2022.06
2021
北榮「法布瑞氏症研究治療中心」 獲SNQ品質標章金質獎金獎
北榮牛道明 榮獲第31屆醫療奉獻獎
北榮牛道明獲醫療奉獻獎殊榮,記者會片段
照顧罕病兒不遺餘力 醫奉獎得主牛道明,頒獎典禮片段
罕病患者的希望 醫界奧斯卡得主無悔奉獻30年
2020
2020中華醫學會兒科醫學之新進展
好時節農莊自己做竹筒飯和Pizza
2019
108年歲末醫護衛教暨病友親子活動
威廉氏症候群病友會
牛道明主任 法布瑞氏症(Fabry) 國內外會議
香港龐貝氏症協會參訪
2018
牛道明主任 中華醫學會法布瑞氏症(Fabry)國內外會議
牛道明主任 107年法布瑞氏症(Fabry)豐碩的研究成果
牛道明主任 107年度「龐貝氏症醫療講座」
罕病新生兒血液濃如「草莓奶昔」 三酸甘油脂飆2萬險致命
2017
牛道明主任 受邀日本法布瑞氏症巡迴演講
牛道明主任 參與國內外醫療會議 紀錄分享
轉載自)TVBS 報導北榮牛道明主任法布瑞氏症(Fabry)-遺傳檢驗儀器捐贈儀式
2016
牛道明主任 法布瑞氏症(Fabry) 國內外會議 國際交流
轉載聯合報-臺北榮總牛道明主任-新生兒基因檢測 竟拯救了這名媽媽
2015
牛道明主任 法布瑞氏症(Fabry) 法布研討會
牛道明主任 台日法布瑞氏症(Fabry)研討會
2014
牛道明主任 至日本福岡分享台灣法布瑞氏症(Fabry)國際會議
牛道明主任 法布瑞氏症(Fabry)國際會議
國際交流 德國 Dr. Max J. Hilz 來訪並發表演講.
2013
牛道明主任 至西班牙法布瑞氏症(Fabry)國際會議
牛道明主任 至日本亞太溶酶體國際會議
牛道明主任團隊 至東京國際會議專題演講
牛道明主任 舉辦法布瑞氏症(Fabry)國際研討會
牛道明主任 法布瑞氏症(Fabry) 衛教講座活動
2012
牛道明主任 遺傳罕病法布瑞氏症 驗血早期發現
承接「台灣法布瑞氏症臨床試驗聯盟」計畫
門診看診流程
龐貝氏症初診流程
甲狀腺低下初診流程
法布瑞氏症初診流程
G6PD蠶豆症看診流程
生長曲線計算機
疾病衛教諮詢
生長激素刺激測試 Clonidine注意事項
水平凝視麻痺併漸進性脊柱側彎
性荷爾蒙檢查與性荷爾蒙藥劑住院常見問題須知
短鏈脂肪酸乙醯輔酶A去水解酶缺乏症
遺傳性高酪胺酸血症第二型
戊二酸血症第一型_發燒腹瀉急診處理
瓜氨酸血症第二型Citrullinemia type II
甲狀腺_用藥劑量衛教單
肝醣儲積症第1A型(Glycogen Storage Disease Type 1A)衛教資料
兒童青春期性早熟發育衛教單
法布瑞氏症 Fabry Disease
原發性肉毒鹼缺乏症
高胱胺酸尿症
腎上腺腦白質失養症Adrenoleukodystrophy
歌舞伎症候群 Kabuki Syndrome
龐貝氏症 (Pompe Disease)
體重過重與口服類固醇抑制測驗門診常見問題須知
羅素-西弗氏症Russell-Silver Syndrome
關於罕病物流中心
物流中心服務流程圖
罕病營養品
Calogen
Phlexy-Vits
PK AID 4
I-Valex-2
Glutarex-2
羅倫佐油
BCAD
Phenyl Free 1
Alfaré
GA1 Anamix
PFD
Essential Amino Acid
Phenyl free 2
HCU Anamix
GENERAID plus
IVA Anamix
Cyclinex-1
Cyclinex-2
Tyrex-1
Tyrex-2
Hominex-2
Pregestimil
I-Valex-1
Glutarex-1
Hominex-1
MMA/PA Anamix
單方胺基酸
罕病藥物
Arginine HCL Injection
BH4
Proglycem
Sodium Benzoate
Stimol
Buphenyl
Cystadane
Sucraid
Normosang
L-Carnitene
罕病相關食物
低蛋白真粒米
實驗室
意見箱
意見箱查詢處理狀況
管理介面(限院內)
下載
Home
Sitemap
中文
International
Branches
Suao
Yuanshan
Taoyuan
Hsinchu
Yu-Li
Fenglin
Taitung
Gan-Dau
Facebook
Home
Profile
:::
張世慶 (Shih-Ching Chang)
Return Appointment
First Appointment
[Profile]
Education
Ph. D., Institute of Clinical Medicine, School of Medicine; National Yang-Ming University, Taipei, Taiwan,
M.D., Medical College; National Yang-Ming University, Taipei, Taiwan,
Career and Experience
Current Positions:
Experiences:
- , Professor of surgery, National Yang-Ming University,
- , Attending physician, Department of Colorectal Surgery, Taipei Veterans General Hospital,
Medical Expertise
Hereditary colorectal cancer and genetic screening
Colonsocopy and polypectomy
Surgery and treatment of colorectal cancer
Anorectal disease
License
Taiwan Surgical Association
The Society of Colon and Rectal Surgeons, Taiwan
[Publications]
Chou CL, Lin JK, Wang HS, Yang SH, Li AF, Chang SC.* Microsatellite instability screening should be done for right-sided colon cancer patients less than 60 years of age. Int J Colorectal Dis 2010;25:47-52. doi:10.1007/s00384-009-0815-y
Chang SC, Lin PC, Yang SH, Wang HS, Liang WY, Lin JK. Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers. Surgery 2010;147:720-8. doi:10.1016/j.surg.2009.10.069
Kao PS, Chang SC, Wang LW, Lee RC, Liang WY, Lin TC, Chen WS, Jiang JK, Yang SH, Wang HS, Lin JK. The impact of preoperative chemoradiotherapy on advanced low rectal cancer. J Surg Oncol 2010;102:771-7. doi:10.1002/jso.21711
Lin JK, Shen MY, Lin TC, Lan YT, Wang HS, Yang SH, Li AF, Chang SC.* Distribution of a single nucleotide polymorphism of insulin-like growth factor-1 in colorectal cancer patients and its association with mucinous adenocarcinoma. Int J Biol Markers 2010;25:195-9
Wang SC, Lin JK, Wang HS, Yang SH, Li AF, Chang SC.* Nuclear expression of CXCR4 is associated with advanced colorectal cancer. Int J Colorectal Dis 2010;25:1185-91. doi:10.1007/s00384-010-0999-1
Lai YL, Lin JK, Liang WY, Huang YC, Chang SC.* Surgical resection combined with chemotherapy can help achieve better outcomes in patients with primary colonic lymphoma. J Surg Oncol 2011;104:265-8. doi:10.1002/jso.21927
Lin JK, Lin CC, Yang SH, Wang HS, Jiang JK, Lan YT, Lin TC, Li AF, Chen WS, Chang SC.* Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer. Int J Colorectal Dis 2011;26:1135-41. doi:10.1007/s00384-011-1209-5
Lin CH, Lin JK, Chang SC, Chang YH, Chang HM, Liu JH, Li LH, Chen YT, Tsai SF, Chen WS. Molecular profile and copy number analysis of sporadic colorectal cancer in Taiwan. J Biomed Sci 2011;18:36. doi:10.1186/1423-0127-18-36
Lin JK, Lin AJ, Lin CC, Lan YT, Yang SH, Li AF, Chang SC.* The status of EGFR-associated genes could predict the outcome and tumor response of chemo-refractory metastatic colorectal patients using cetuximab and chemotherapy. J Surg Oncol 2011;104:661-6. doi:10.1002/jso.21993
Hwang WL, Yang MH, Tsai ML, Lan HY, Su SH, Chang SC, Teng HW, Yang SH, Lan YT, Chiou SH, Wang HW. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 2011;141:279-91, 91 e1-5. doi:10.1053/j.gastro.2011.04.008
Lin JK, Yueh TC, Chang SC, Lin CC, Lan YT, Wang HS, Yang SH, Jiang JK, Chen WS, Lin TC. The influence of fecal diversion and anastomotic leakage on survival after resection of rectal cancer. J Gastrointest Surg 2011;15:2251-61. doi:10.1007/s11605-011-1721-5
Chou CL, Chang SC, Lin TC, Chen WS, Jiang JK, Wang HS, Yang SH, Liang WY, Lin JK. Differences in clinicopathological characteristics of colorectal cancer between younger and elderly patients: an analysis of 322 patients from a single institution. Am J Surg 2011;202:574-82. doi:10.1016/j.amjsurg.2010.10.014
Lin CC, Lai YL, Lin TC, Chen WS, Jiang JK, Yang SH, Wang HS, Lan YT, Liang WY, Hsu HM, Lin JK, Chang SC.* Clinicopathologic features and prognostic analysis of MSI-high colon cancer. Int J Colorectal Dis 2012;27:277-86. doi:10.1007/s00384-011-1341-2
Lin PC, Lin JK, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Li AF, Chen WS, Chang SC.* Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis. Int J Colorectal Dis 2012;27:1333-8. doi:10.1007/s00384-012-1447-1
Chou CL, Weng SF, Lin JK, Chang SC.* Role for gender in colorectal cancer risk: a Taiwan population-based study. Int J Colorectal Dis 2013;28:1001-8. doi:10.1007/s00384-013-1647-3
Lin PC, Lin HH, Lin JK, Lin CC, Yang SH, Li AF, Chen WS, Chang SC.* Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy--preliminary evidence. Int J Biol Markers 2013;28:182-6. doi:10.5301/jbm.5000004
Fang WL, Chang SC, Lan YT, Huang KH, Chen JH, Lo SS, Hsieh MC, Li AF, Wu CW, Chiou SH. Microsatellite instability is associated with a better prognosis for gastric cancer patients after curative surgery. World J Surg 2012;36:2131-8. doi:10.1007/s00268-012-1652-7
Fang WL, Chang SC, Lan YT, Huang KH, Lo SS, Li AF, Chi CW, Wu CW, Chiou SH. Molecular and survival differences between familial and sporadic gastric cancers. Biomed Res Int 2013;2013:396272. doi:10.1155/2013/396272
Lu YJ, Lin PC, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Liang WY, Chen WS, Lin JK, Chang SC*. The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients. World J Surg 2013;37:1927-33. doi:10.1007/s00268-013-2051-4
Shao YC, Chang YY, Lin JK, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Li AF, Chen WS, Chang SC.* Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasis. Int J Colorectal Dis 2013;28:1359-65. doi:10.1007/s00384-013-1713-x
Lin HH, Lin JK, Lin CC, Lan YT, Wang HS, Yang SH, Jiang JK, Chen WS, Lin TC, Liang WY, Chang SC*. Circumferential margin plays an independent impact on the outcome of rectal cancer patients receiving curative total mesorectal excision. Am J Surg 2013;206:771-7. doi:10.1016/j.amjsurg.2013.03.009
Huang CS, Lin JK, Wang LW, Liang WY, Lin CC, Lan YT, Wang HS, Yang SH, Jiang JK, Chen WS, Lin TC, Chang SC*. Assessment of the value of carcinoembryonic antigen reduction ratio as a prognosis factor in rectal cancer. Am J Surg 2014;208:99-105. doi:10.1016/j.amjsurg.2013.08.054
Lin CC, Lin JK, Lin TC, Chen WS, Yang SH, Wang HS, Lan YT, Jiang JK, Yang MH, Chang SC*. The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer. J Surg Oncol 2014;110:451-7. doi:10.1002/jso.23675
Lin HH, Chang YY, Lin JK, Jiang JK, Lin CC, Lan YT, Yang SH, Wang HS, Chen WS, Lin TC, Chang SC*. The role of adjuvant chemotherapy in stage II colorectal cancer patients. Int J Colorectal Dis 2014;29:1237-43. doi:10.1007/s00384-014-1943-6
Lin JK, Lin PC, Lin CH, Jiang JK, Yang SH, Liang WY, Chen WS, Chang SC*. Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors. Ann Surg Oncol 2014;21 Suppl 4:680-6. doi:10.1245/s10434-014-3804-5
Lan YT, Yang SH, Lin JK, Lin CC, Wang HS, Chen WS, Lin TC, Jiang JK, Chang SC*. Genetic variations are associated with lymph node metastasis in colorectal cancer patients. J Surg Oncol 2014;110:307-12. doi:10.1002/jso.23613
Lin PC, Lin JK, Lin CH, Lin HH, Yang SH, Jiang JK, Chen WS, Chou CC, Tsai SF, Chang SC*. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array. Ann Surg Oncol 2014. doi:10.1245/s10434-014-4277-
Hang JF, Li AF, Chang SC, Liang WY. Immunohistochemical detection of BRAF V600E mutant protein in colorectal cancers in Taiwan is highly concordant with the molecular test. Histopathology 2015. doi:10.1111/his.12903Chang SC, Lin PC, Lin JK, Lin CH, Yang SH, Liang WY, Chen WS, Jiang JK. Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis. Ann Surg Oncol 2015. doi:10.1245/s10434-015-4899-z
Lin HH, Yang HL, Lin JK, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Chen WS, Liang WY, Chang SC. The Number of Risk Factors Determines the Outcome Of Stage II Colorectal Cancer Patients. Hepatogastroenterology 2014;61:1024-7
Lee YT, Liu CJ, Hu YW, Teng CJ, Tzeng CH, Yeh CM, Chen TJ, Lin JK, Lin CC, Lan YT, Wang HS, Yang SH, Jiang JK, Chen WS, Lin TC, Chang SC, Chen MH, Teng HW, Liu JH, Yen CC. Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan. Medicine (Baltimore) 2015;94:e1079. doi:10.1097/md.0000000000001079
Lin PC, Lin JK, Lin HH, Lan YT, Lin CC, Yang SH, Chen WS, Liang WY, Jiang JK, Chang SC. A comprehensive analysis of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss in colorectal cancer. World J Surg Oncol 2015;13:186. doi:10.1186/s12957-015-0601-y
Lan YT, Jen-Kou L, Lin CH, Yang SH, Lin CC, Wang HS, Chen WS, Lin TC, Jiang JK, Chang SC. Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers. J Surg Oncol 2015;111:905-10. doi:10.1002/jso.23895
Huang CS, Yang SH, Lin CC, Lan YT, Chang SC, Wang HS, Chen WS, Lin TC, Lin JK, Jiang JK. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses? Hepatogastroenterology 2015;62:286-90
Chang YY, Lin JK, Lin TC, Chen WS, Jeng KJ, Yang SH, Wang HS, Lan YT, Lin CC, Liang WY, Chang SC. Impact of KRAS mutation on outcome of patients with metastatic colorectal cancer. Hepatogastroenterology 2014;61:1946-53
Huang SC, Lin JK, Lin TC, Chen WS, Yang SH, Wang HS, Lan YT, Lin CC, Jiang JK, Chang SC. Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy. Ann Surg Oncol 2015;22:2262-8. doi:10.1245/s10434-014-4228-y
回到最上